Senior insider sale
SVP & General Counsel at NEKTAR THERAPEUTICS — senior position signals high conviction
$5.70M
78.51K shares
What this filing means
WILSON MARK ANDREW plans to sell 78.51K shares of NEKTAR THERAPEUTICS valued at approximately $5.70M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/13/2026ACC: 0001959173-26-002286
Officer· SVP & General Counsel
Since Mar 2020
78.51K
Shares to sell
$5.70M
Approx. market value
78.51K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months3
Option Granted - 12/13/2024
Cash
3/13/2026
5.41KOption Granted - 08/15/2022
Cash
3/13/2026
44.25KOption Granted - 12/13/2023
Cash
3/13/2026
28.85KTotal acquired78.51K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/13/2026 | Option Granted - 12/13/2024 Cash | 5.41K | — |
3/13/2026 | Option Granted - 08/15/2022 Cash | 44.25K | — |
3/13/2026 | Option Granted - 12/13/2023 Cash | 28.85K | — |
| Total | 78.51K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
78.51K
Market value
$5.70M
3/13/2026
Total
Units
78.51K
Value
$5.70M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/13/2026 | 78.51K | $5.70M | NASDAQ | Planned |
| Total | 78.51K | $5.70M | ||